These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36612704)

  • 21. Clinical predictors of incomplete coronary sinus lead removal during transvenous lead extraction in patients with cardiac resynchronization therapy.
    Hayashi K; Younis A; Callahan T; Baranowski B; Martin DO; Nakhla S; Wilkoff BL
    Heart Rhythm; 2023 Jun; 20(6):872-878. PubMed ID: 36933853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable loop recorder as a strategy following cardiovascular implantable electronic device extraction without reimplantation.
    Birs A; Darden D; Eskander M; Pollema T; Ho G; Birgersdotter-Green U
    Pacing Clin Electrophysiol; 2022 Jul; 45(7):853-860. PubMed ID: 35587876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.
    Regoli F; Bongiorni MG; Rordorf R; Santamaria M; Klersy C; Segreti L; De Regibus V; Moccetti T; Conte G; Caputo ML; Auricchio A
    Eur J Heart Fail; 2016 Oct; 18(10):1270-1277. PubMed ID: 27170594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transvenous Lead Extraction without Procedure-Related Deaths in 1000 Consecutive Patients: A Single-Center Experience.
    Stefańczyk P; Nowosielecka D; Tułecki Ł; Tomków K; Polewczyk A; Jacheć W; Kleinrok A; Borzęcki W; Kutarski A
    Vasc Health Risk Manag; 2021; 17():445-459. PubMed ID: 34385818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transvenous lead extraction safety and efficacy in infected and noninfected patients using mechanical-only tools: Prospective registry from a high-volume center.
    Gładysz-Wańha S; Joniec M; Wańha W; Piłat E; Drzewiecka A; Gardas R; Biernat J; Węglarzy A; Gołba KS
    Heart Rhythm; 2024 Apr; 21(4):427-435. PubMed ID: 38157921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transvenous Lead Extraction in Pediatric Patients　- Is It the Same Procedure in Children as in Adults?
    Kutarski A; Miszczak-Knecht M; Brzezinska M; Birbach M; Lipiński W; Polewczyk AM; Jacheć W; Polewczyk A; Tułecki Ł; Tomków K; Stefańczyk P; Nowosielecka D; Bieganowska K
    Circ J; 2023 Jun; 87(7):990-999. PubMed ID: 36517020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of transvenous lead extraction in patients on minimally interrupted periprocedural direct oral anticoagulation therapy.
    Issa ZF; Elayyan MAM
    J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2722-2728. PubMed ID: 34322933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional Disparities in Transvenous Lead Extraction for Cardiac Implantable Electronic Device Infection in Japan　- A Descriptive Study Using the National Database Open Data.
    Togashi S; Isawa T; Honda T; Furuya K; Yamaya K; Taguri M; Toyoda S
    Circ J; 2023 Jun; 87(7):1000-1006. PubMed ID: 37197942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of age on in-hospital outcomes of transvenous lead extraction for infected cardiac implantable electronic device.
    Tan MC; Ang QX; Yeo YH; Thong JY; Tolat A; Scott LR; Lee JZ
    Pacing Clin Electrophysiol; 2024 Apr; 47(4):577-582. PubMed ID: 38319639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of transvenous lead extraction in the management of redundant or malfunctioning pacemaker and defibrillator leads post ELECTRa.
    Sidhu BS; Gould J; Sieniewicz B; Porter B; Rinaldi CA
    Europace; 2018 Nov; 20(11):1733-1740. PubMed ID: 29452360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes following transvenous lead extraction: Data from a tertiary referral center.
    Arabia G; Mitacchione G; Cersosimo A; Calvi E; Salghetti F; Bontempi L; Giacopelli D; Cerini M; Curnis A
    Int J Cardiol; 2023 May; 378():32-38. PubMed ID: 36841289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes.
    Bongiorni MG; Kennergren C; Butter C; Deharo JC; Kutarski A; Rinaldi CA; Romano SL; Maggioni AP; Andarala M; Auricchio A; Kuck KH; Blomström-Lundqvist C;
    Eur Heart J; 2017 Oct; 38(40):2995-3005. PubMed ID: 28369414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Financial and resource costs of transvenous lead extraction in a high-volume lead extraction centre.
    Gould J; Sidhu BS; Porter B; Sieniewicz BJ; Freeman S; de Wilt EC; Glover JC; Razavi R; Rinaldi CA
    Heart; 2020 Jun; 106(12):931-937. PubMed ID: 31932286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost of CIED infectious complications treatment in Poland from the perspective of Polish hospitals.
    Romanek J; Farkowski M; Bukowski H; Gołba K; Wita K; Mitkowski P; Przybylski A
    Kardiol Pol; 2022; 80(9):919-925. PubMed ID: 35698969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of transvenous leads extractions implanted more than 10 years before.
    Maciąg A; Syska P; Przybylski A; Kuśmierski K; Sterliński M; Oręziak A; Pytkowski M; Różański J; Szwed H
    Cardiol J; 2014; 21(4):419-24. PubMed ID: 24142680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transvenous removal of cardiac implantable electronic device leads.
    Ribeiro S; Leite L; Oliveira J; Pereira MJ; Pinheiro C; Ermida P; António N; Ventura M; Cristóvão J; Elvas L; Providência L
    Rev Port Cardiol; 2015 Dec; 34(12):739-44. PubMed ID: 26596378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transesophageal echocardiography for the monitoring of transvenous lead extraction.
    Nowosielecka D; Polewczyk A; Jacheć W; Kleinrok A; Tułecki Ł; Kutarski A
    Kardiol Pol; 2020 Dec; 78(12):1206-1214. PubMed ID: 33078921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies and outcomes of patients with severely reduced ejection fraction (≤15%) undergoing transvenous lead extraction: A single-center experience.
    Arora Y; Llaneras N; Carrillo R
    Heart Rhythm; 2022 Dec; 19(12):2002-2008. PubMed ID: 35948204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of skin erosion and local pocket infections in population of patients with cardiac implantable electronic devices undergoing transvenous lead extraction.
    Polewczyk A; Jacheć W; Kutarski A
    J Cardiovasc Electrophysiol; 2022 Aug; 33(8):1857-1862. PubMed ID: 35761750
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lead extraction in cardiac implantable electronic devices].
    Reinhardt A; Jansen H; Althoff T; Estner H; Iden L; Busch S; Rillig A; Johnson V; Sommer P; Tilz RR; Steven D; Duncker D
    Herzschrittmacherther Elektrophysiol; 2023 Dec; 34(4):339-350. PubMed ID: 37917360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.